Ex-PRESS glaucoma filtration device (Alcon Inc.) for treatment of primary open-angle glaucoma

Record ID 32011001487
English
Authors' objectives:

Glaucoma refers to a group of eye diseases in which vision is lost due to damage of the optic nerve, which carries visual information from the eye to the brain. Glaucoma is estimated to affect 4 million people in the United States, and it is the second leading cause of blindness. Though it is not
preventable, treatments are available that may slow the progression of glaucoma, so early detection is very important. Treatments for glaucoma may include eye drops, laser surgery, or incisional surgery. The aim of treatment is to reduce the pressure of the fluid in the eye, known as intraocular
pressure (IOP), in an attempt to prevent further damage to the optic nerve. There are several different types of glaucoma, and the most common type is known as primary open-angle glaucoma (POAG). In patients with POAG, fluid may not drain out of the eye properly, despite there being no physical blockages evident.

Details
Project Status: Completed
Year Published: 2011
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Equipment Design
  • Filtering Surgery
  • Glaucoma
Contact
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name: saleinfo@hayesinc.com
Contact Email: saleinfo@hayesinc.com
Copyright: <p>2011 Winifred S. Hayes, Inc</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.